ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0066

Mitochondrial Dysfunction and Fatigue in Sjögren’s Disease

Biji T Kurien1, Rebecca Wood2, Gavin Pharaoh3, Joshua Cavett1, Valerie Lewis1, Bhaskaran Shylesh1, Lida radfar1, Astrid Rasmussen1, Christopher Lessard1, A. Darise Farris1, Kathy Sivils4, Kristi Koelsch1, Holly Van Remmen1 and R Hal Scofield5, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Edmond, OK, 3University of Washington, Seattle, WA, 4Janssen Research & Development, LLC, Edmond, OK, 5Oklahoma City Veterans Affairs Medical Center, Oklahoma City, OK

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Fatigue, Mitochondrial Dysfunction, Sjögren's syndrome, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0066–0095) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Sjögren’s disease (SjD) is a chronic, autoimmune condition with diminished lacrimal and salivary gland secretion leading to keratoconjunctivitis sicca and xerostomia, respectively. In addition, subjects with SjD experience significant fatigue. We hypothesized that SjD subjects have mitochondrial dysfunction and that fatigue will be associated with mitochondrial dysfunction in a subset of subjects with SjD.

Methods: Seventeen SjD subjects and eight age-matched subjects underwent a fasting blood draw and completed fatigue questionnaires (Bowman’s SjD, Fatigue Impact Scale, Multidimensional assessment of fatigue, Centers for Epidemiological Studies-Depression Scale, Fatigue Severity Scale, The Rheumatology Attitudes Index or Helplessness Score, Modified Health Assessment, Validation of the Functioning in Chronic Illness Scale, SLEEP 1, and SLEEP 2). T cells were purified through negative selection using Miltenyi Biotech B and T cell isolation kit and analyzed for mitochondrial oxygen consumption rate and extracellular acidification rate (glycolysis) using the Seahorse XF24 assay. Mitochondrial macrostructure of PBMC’s isolated from SjD or control subjects was analyzed using transmission electron microscopy.

Results: There was no significant difference in the ages of the controls and the SjD subjects (52.25 years ± 3.21 vs 59.88 years ± 3.17 respectively, p=0.17) and there were no age-related changes in the oxygen consumption rate. However, we observed significantly decreased basal, ATP-linked, and maximal respiration as well as reserve capacity in the T cells of SjD subjects compared to controls. We found that scores from the Bowman fatigue questionnaire correlated the best with basal oxygen consumption (r2=0.34, p=0.014), ATP-linked respiration (r2=0.36, p=0.011), maximal respiration (r2=0.491, p=0.0017), and reserve capacity (r2=0.486, p=0.0019) in SjD. Scores from the general fatigue category (pain/discomfort) related to the question “the worst problem with pains, the worst discomfort I’ve experienced in 2 weeks” provided most of the power for these associations. Scores from Bowman mental fatigue questionnaire showed a trend towards correlating with ATP-linked respiration (r2=0.22, p=0.0588). Fatigue Severity Scale scores correlated only with mitochondrial reserve capacity in SjD (r2=0.244, p=0.044). Transmission electron microscopy studies clearly show swollen mitochondria in the lymphocytes from SjD, with the cristae appearing to be prominently disorganized compared to mitochondria from the control.

Conclusion: Mitochondrial dysfunction, associated with fatigue, appears to be a significant problem in SjD.


Disclosures: B. Kurien: None; R. Wood: None; G. Pharaoh: None; J. Cavett: None; V. Lewis: None; B. Shylesh: None; L. radfar: None; A. Rasmussen: None; C. Lessard: Janssen, 5; A. Farris: Janssen Research and Development, LLC, 5; K. Sivils: Janssen, 3; K. Koelsch: None; H. Van Remmen: None; R. Scofield: None.

To cite this abstract in AMA style:

Kurien B, Wood R, Pharaoh G, Cavett J, Lewis V, Shylesh B, radfar L, Rasmussen A, Lessard C, Farris A, Sivils K, Koelsch K, Van Remmen H, Scofield R. Mitochondrial Dysfunction and Fatigue in Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/mitochondrial-dysfunction-and-fatigue-in-sjogrens-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mitochondrial-dysfunction-and-fatigue-in-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology